Xiwei Wu
Impact in
- Cancer Research top 0.5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 0.5%
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- Cancer-related gene regulation
- Circular RNAs in diseases
- CRISPR and Genetic Engineering
- Extracellular vesicles in disease
Papers in
-
- Epigenetics and DNA Methylation 39
- RNA modifications and cancer 27
- Cancer-related gene regulation 13
-
- MicroRNA in disease regulation 24
- Cancer-related molecular mechanisms research 23
- Co-authors
- Gerd P. Pfeifer (25 shared papers)Tibor A. Rauch (7 shared papers)Arthur D. Riggs (19 shared papers)Arthur X. Li (14 shared papers)Xueyan Zhong (6 shared papers)Seung‐Gi Jin (5 shared papers)Shizhen Emily Wang (9 shared papers)Yate‐Ching Yuan (19 shared papers)
- Journals
- Blood (15 papers)Cancer Research (13 papers)PLoS ONE (9 papers)Nucleic Acids Research (7 papers)Nature Communications (7 papers)
- Partner nations
- United StatesChinaTaiwan
In The Last Decade
Xiwei Wu
208 papers receiving 10.3k citations
Xiwei Wu's Hit Papers
Peers
Comparison fields: 5 of 151
- Cancer Research 2.5k
- Molecular Biology 6.8k
- Oncology 1.5k
- Immunology 1.0k
- Genetics 1.3k
Countries citing papers authored by Xiwei Wu
This map shows the geographic impact of Xiwei Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiwei Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiwei Wu more than expected).
Fields of papers citing papers by Xiwei Wu
This network shows the impact of papers produced by Xiwei Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiwei Wu. The network helps show where Xiwei Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiwei Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 216 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 372 | |
| 2 | Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent metabolic reprogramming of stromal cells Hit paper breakdown → | 2018 | 372 |
| 3 | 2015 | 369 | |
| 4 | 2012 | 340 | |
| 5 | 2016 | 336 | |
| 6 | 2011 | 313 | |
| 7 | 2009 | 269 | |
| 8 | 2007 | 252 | |
| 9 | 2011 | 246 | |
| 10 | 2006 | 242 | |
| 11 | 2010 | 240 | |
| 12 | 2007 | 235 | |
| 13 | 2014 | 200 | |
| 14 | 1996 | 186 | |
| 15 | 2007 | 156 | |
| 16 | 2014 | 155 | |
| 17 | 2012 | 155 | |
| 18 | 2019 | 152 | |
| 19 | 2010 | 148 | |
| 20 | 2009 | 126 |
About Xiwei Wu
Xiwei Wu is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Genetics, having authored 216 papers that have together received 10.4k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (39 papers), RNA modifications and cancer (27 papers), MicroRNA in disease regulation (24 papers), Cancer-related molecular mechanisms research (23 papers), Cutaneous lymphoproliferative disorders research (14 papers), Immune Cell Function and Interaction (14 papers), Cancer-related gene regulation (13 papers) and CAR-T cell therapy research (12 papers). The work is most often cited by research in Cancer Research (2.5k citations), Molecular Biology (6.8k citations), Oncology (1.5k citations), Immunology (1.0k citations) and Genetics (1.3k citations). Xiwei Wu has collaborated with scholars based in United States, China and Taiwan. Frequent co-authors include Gerd P. Pfeifer, Tibor A. Rauch, Arthur D. Riggs, Arthur X. Li, Xueyan Zhong, Seung‐Gi Jin, Shizhen Emily Wang, Yate‐Ching Yuan, Jun Wu and Rama Natarajan. Their work appears in journals such as Blood, Cancer Research, PLoS ONE, Nucleic Acids Research and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.